
    
      -  In Treatment Period 1, subjects will receive a single 25 mg oral dose of IPI-145

        -  In Treatment Period 2, on Days 3-9, the same subjects will receive once daily (QD) oral
           doses of 600 mg rifampin; on Day 9, subjects will receive a single oral dose of 25 mg
           IPI-145 concomitantly administered with 600 mg of rifampin
    
  